INBRAIN Neuroelectronics, a clinical-stage neurotechnology company, has been named a 2025 Technology Pioneer by the World Economic Forum, recognizing its groundbreaking work in developing graphene-based brain-computer interfaces (BCIs). This prestigious honor underscores INBRAIN’s role in redefining how neurological disorders are treated—through ultra-thin, biocompatible neural implants that decode and modulate brain signals in real time. The company’s core innovation lies in the use of graphene, a material with exceptional electrical and mechanical properties, enabling minimally invasive implants with micrometric precision and real-time adaptability.
INBRAIN’s platform is designed to deliver personalized, closed-loop neuroelectronic therapies for conditions such as Parkinson’s disease, epilepsy, and stroke-related impairments. These intelligent implants use AI to interpret neural signals and modulate them therapeutically, offering dynamic, patient-specific interventions. By combining data-driven insights with biological feedback, INBRAIN is building a new standard of neurocare—one that is adaptive, outcomes-based, and clinically actionable. The company’s approach opens the door for reimbursement models tied to measurable therapeutic success, making it both medically impactful and economically viable.
Receiving the World Economic Forum’s Technology Pioneer award places INBRAIN among a select group of companies shaping the future of their industries. It not only validates the company’s technological leadership but also positions it to influence global health policy and innovation agendas. With ongoing support, including a €4 million grant from the Spanish Ministry of Industry and Tourism, INBRAIN is poised to accelerate the development of next-generation BCIs. As part of the WEF cohort, INBRAIN will collaborate with international stakeholders to drive advancements in neurotechnology, with the ultimate goal of transforming care for millions of patients worldwide.
MedTech Spectrum's Summary
Global Recognition for Neurotech Innovation: INBRAIN Neuroelectronics has been named a 2025 World Economic Forum Technology Pioneer for its pioneering work in graphene-based brain-computer interfaces, reinforcing its leadership in precision neuromodulation.
Transforming Neurological Care: INBRAIN’s intelligent, minimally invasive BCI platform enables real-time decoding and modulation of brain signals, offering personalized therapies for conditions like Parkinson’s disease, epilepsy, and stroke recovery.
Shaping the Future of Precision Medicine: Backed by international recognition and public funding, INBRAIN is driving a new era of adaptive, data-driven neurotherapies with the potential to set new clinical standards and influence global health innovation.
